Innovation MESH Network | Mass General Brigham

Asset 5
Sign in Sign up

  • Home
  • Courses
  • Find-an-Innovator
  • Grand Rounds
  • Innovation Funding
    • Internal
    • External
  • Instructors
  • About
Sign in Sign up
logo nomgb SMALL
  • Home
  • Courses
  • Find-an-Innovator
  • Grand Rounds
  • Innovation Funding
    • Internal
    • External
  • Instructors
  • About

Course Tag: diagnostics

Mass General Brigham Innovation MESH Core

MGB Innovation MESH Core: Healthcare Innovation Bootcamp is the official innovation course of Mass General Brigham. This award-winnin…

A la carte: Technology Solutions Now and in the Future (WMIF)

Experts leading large teams at the epicenter of the coronavirus outbreak discuss how technology is shaping the pandemic response today and in the coming years.…

A la carte: The Fundamentals of Artificial Intelligence and Machine Learning, with Real Demos! (MESH CORE)

Artificial Intelligence (AI) has arrived and it’s changing healthcare. Being able to ac…

A la carte: BIOGEN CEO: Keeping Priority on the Biggest Diseases (WMIF)

Biogen CEO Michel Vounatsos will discuss how Biogen is tackling some of society’s most devastating neurological and neurodegenerative disorders, and share his perspective on the…

A la carte: Accelerating Diagnostics and Maintaining the Priority: Lab, Home, and Digital (WMIF)

COVID-19 diagnostics, a linchpin in controlling viral spread — what caused testing in the U.S. to fall so far behind and how can those missteps…

Contact Info

Mass General Brigham Innovation

innovation.massgeneralbrigham.org

One Main Street, Suite 501
Cambridge, MA 02142

Twitter
Register Now!
Contact Info

MESH Incubator, Mass General Brigham

meshincubator.org

55 Fruit Street, Blake 258,
Boston, MA 02114

617-726-2000

hello@meshincubator.org

Twitter
Register Now!
Copyright © 2023 Innovation MESH Network | Mass General Brigham INCORPORATED. ALL RIGHTS RESERVED.

Disclaimer   Privacy Policy

Forum Description

COVID-19 diagnostics, a linchpin in controlling viral spread — what caused testing in the U.S. to fall so far behind and how can those missteps be prevented in the future? How do the diagnostics industry, and academic medicine, develop the tests that enable group activities including businesses sports, and community? What is the profile of diagnostic tests coming online in the coming months and into next year? What lessons can be learned to guide the global health community in future disease outbreaks? Given the biological complexity, required performance standards, and immense volume is a simple DTC assays possible on a greatly accelerated timeline. Moderator: Jeffrey Golden, MD, Chair, Department of Pathology, BH; Ramzi S. Cotran Professor of Pathology, HMS James Brink, MD, Chief, Department of Radiology, MGH; Juan M. Taveras Professor of Radiology, HMS John Iafrate, MD, PhD, Vice Chair, Academic Affairs, MGH; Professor, Pathology, HMS Celine Roger-Dalbert, VP Diagnostic Assays R&D – Integrated Diagnostic Solutions, BD Life Sciences Matt Sause, President and CEO, Roche Diagnostics Corporation

Report

There was a problem reporting this post.

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .
Clear Clear All